ARCHIVES

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

This article is from The Cancer Letter archive.

Vol. 20 No. 42 | November 4, 1994

Download PDF Visit The Full Archive

Related Articles

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

In Brief: FY 1985 Budget Breakdown; Control Gets $64 Million, Construction $6.5; W. VA. $4.5 Maybe

November 9, 1984

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011